Inovio Pharmaceuticals HIV Immunotherapy Shows Characteristics Considered Vital to Treating HIV
January 06, 2015 at 08:01 AM EST
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today that results from a 12-patient phase I study of Inovio's HIV immunotherapy, ...